arXiv subjects

Simon Süwer

Publications and source records attributed to Simon Süwer.

3 recordsLinked to original sources

arXiv2026

Biomedical systems biology workflow orchestration and execution with PoSyMed

The rapid growth of scientific software has created practical barriers for bioinformatics research. Although powerful statistical, artificial intelligence (AI)-based methods are now widely available, their effective use is often hindered by fragmented distribution, inconsistent documentation, complex dependencies, and difficult-to-reproduce execution environments. As a result, reusing published tools and workflow adaptation to own date remains technically demanding and time-intensive, even for experienced users. Here, we present PoSyMed, an open and modular platform for the controlled integration, composition, and execution of bioinformatics tools and workflows. PoSyMed combines a backend-centered platform architecture with formal tool descriptions, controlled container-based build and execution processes, persistent workflow state, and a dialogue-based user interface. Large language models (LLM) are integrated not as autonomous decision-makers, but as human-computer interface with bounded semantic assistants that help identify tools, propose workflow steps, and support parameterization within a typed, validated, and human-supervised execution environment. PoSyMed is designed to improve reproducibility, traceability, and transparency in practical biomedical analysis within one platform. We describe the system architecture and evaluate its behavior across representative biological software scenarios with respect to workflow support, interaction design, and platform extensibility. PoSyMed is publicly available at https://apps.cosy.bio/posymed.

cs.SE↗

arXiv2026

Conversational No-code, Multi-agentic Disease Module Identification and Drug Repurposing Prediction with ChatDRex

Repurposing approved drugs offers a time-efficient and cost-effective alternative to traditional drug development. However, in silico prediction of repurposing candidates is challenging and requires the effective collaboration of specialists in various fields, including pharmacology, medicine, biology, and bioinformatics. Fragmented, specialized algorithms and tools often address only narrow aspects of the overall problem. Heterogeneous, unstructured data landscapes require the expertise of specialized users. Hence, these data services do not integrate smoothly across workflows. With ChatDRex, we present a conversation-based, multi-agent system that facilitates the execution of complex bioinformatic analyses aiming for network-based drug repurposing prediction. It builds on the integrated systems medicine knowledge graph (NeDRex KG). ChatDRex provides natural language access to its extensive biomedical knowledge base. It integrates bioinformatics agents for network analysis, literature mining, and drug repurposing. These are complemented by agents that evaluate functional coherence for in silico validation. Its flexible multi-agent design assigns specific tasks to specialized agents, including query routing, data retrieval, algorithm execution, and result visualization. A dedicated reasoning module keeps the user in the loop and allows for hallucination detection. By enabling physicians and researchers without computer science expertise to control complex analyses with natural language, ChatDRex democratizes access to bioinformatics as an important resource for drug repurposing. It enables clinical experts to generate hypotheses and explore drug repurposing opportunities, ultimately accelerating the discovery of novel therapies and advancing personalized medicine and translational research. ChatDRex is publicly available at apps.cosy.bio/chatdrex.

cs.AI↗

arXiv2025

A Privacy-Preserving Ecosystem for Developing Machine Learning Algorithms Using Patient Data: Insights from the TUM.ai Makeathon

The integration of clinical data offers significant potential for the development of personalized medicine. However, its use is severely restricted by the General Data Protection Regulation (GDPR), especially for small cohorts with rare diseases. High-quality, structured data is essential for the development of predictive medical AI. In this case study, we propose a novel, multi-stage approach to secure AI training: (1) The model is designed on a simulated clinical knowledge graph (cKG). This graph is used exclusively to represent the structural characteristics of the real cKG without revealing any sensitive content. (2) The model is then integrated into the FeatureCloud (FC) federated learning framework, where it is prepared in a single-client configuration within a protected execution environment. (3) Training then takes place within the hospital environment on the real cKG, either under the direct supervision of hospital staff or via a fully automated pipeline controlled by the hospital. (4) Finally, verified evaluation scripts are executed, which only return aggregated performance metrics. This enables immediate performance feedback without sensitive patient data or individual predictions, leaving the clinic. A fundamental element of this approach involves the incorporation of a cKG, which serves to organize multi-omics and patient data within the context of real-world hospital environments. This approach was successfully validated during the TUM.ai Makeathon 2024 (TUMaiM24) challenge set by the Dr. von Hauner Children's Hospital (HCH-LMU): 50 students developed models for patient classification and diagnosis without access to real data. Deploying secure algorithms via federated frameworks, such as the FC framework, could be a practical way of achieving privacy-preserving AI in healthcare.

cs.DC↗